EDWARDS LIFESCIENCES LLC EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 11500A |
Device Problem
Gradient Increase (1270)
|
Patient Problems
Dyspnea (1816); Insufficient Information (4580)
|
Event Date 08/14/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: the subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was reported that a 27mm 11500a aortic valve was disabled after an implant duration of four years, eight months due to stenosis.The tavr procedure was completed with a 26mm 9750tfx transcatheter valve without complications.
|
|
Event Description
|
It was reported that a 27mm 11500a aortic valve was disabled after an implant duration of four years, eight months due to stenosis.The patient presented with shortness of breath.The tavr procedure was completed with a 26mm 9750tfx transcatheter valve without complications.
|
|
Manufacturer Narrative
|
Updated sections: b4, b5, b7, g3, g6, h2, h6 (clinical code, and type of investigation).
|
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: updated sections: h6 (type of investigation, investigation findings, and investigation conclusions).The device history record (dhr) review was completed, and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Engineering evaluation summary: stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potentials known and unknown patient-related contributing factors.Per technical summary (b)(4), rev a, structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Stenosis is most commonly related to patient factors and is not usually an indication of a device malfunction.The most likely cause is patient factors, including a history of hyperlipidemia, diabetes mellitus and atherosclerosis.All pertinent information available to edwards lifesciences has been submitted.
|
|
Search Alerts/Recalls
|
|
|